---
title: "Vogenx (VOGX) news: going concern, IPO and offering"
url: "https://aibio.space/companies/vogenx/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "VOGX going concern, IPO and offering news: Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq. Vogenx Inc (NASDAQ: VOGX), United States."
---

VOGX Vogenx Inc NASDAQ · United States

# Vogenx (VOGX) news VOGX going concern, IPO and offering news

Financings · 2026-08-12

## [Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq](https://aibio.space/news/vogenx-prices-ipo-6-250-000-shares-13-00-nasdaq/)

Vogenx priced 6,250,000 shares at $13.00, for $81,250,000 before underwriting discounts. The prospectus shows $251 thousand of cash at March 31, 2026 and a going-concern warning.

## Latest Vogenx news

1. 2026-07-15 Financings [Vogenx files for IPO, plans Nasdaq Capital Market listing as VOGX](https://aibio.space/news/vogenx-files-ipo-plans-nasdaq-capital-market-listing-vogx/) Vogenx filed a Form S-1 on July 15, 2026 for an initial public offering with the share count and price still blank. The filing reports $251 thousand of cash on March 31, 2026, and its financial statements carry going-concern doubt.

## Vogenx at a glance

- **Ticker**: VOGX

- **Listing**: NASDAQ

- **Country**: United States

### Related companies

- [Viking Therapeutics](https://aibio.space/companies/viking-therapeutics/) NASDAQ: VKTX
- [Eli Lilly](https://aibio.space/companies/eli-lilly/) NYSE: LLY
- [Kaleido Biosciences](https://aibio.space/companies/kaleido-biosciences/) OTC: KLDO
- [Aligos Therapeutics](https://aibio.space/companies/aligos-therapeutics/) NASDAQ: ALGS
- [Immix Biopharma](https://aibio.space/companies/immix-biopharma/) NASDAQ: IMMX
- [Compass Therapeutics](https://aibio.space/companies/compass-therapeutics/) NASDAQ: CMPX
- [Aktis Oncology](https://aibio.space/companies/aktis-oncology/) NASDAQ: AKTS
- [Amphastar Pharmaceuticals](https://aibio.space/companies/amphastar-pharmaceuticals/) NASDAQ: AMPH

### Also on NASDAQ

- [Hemab Therapeutics Holdings](https://aibio.space/companies/hemab-therapeutics/) COAG
- [TRINITY BIOTECH](https://aibio.space/companies/trinity-biotech/) TRIB
- [Longeveron](https://aibio.space/companies/longeveron/) LGVN
- [SciSparc](https://aibio.space/companies/scisparc/) SPRC
- [SS Innovations International](https://aibio.space/companies/ss-innovations-international/) SSII
- [QTREX Quantum](https://aibio.space/companies/qtrex-quantum/) QTEX

## Questions about Vogenx

Has Vogenx issued a going-concern warning?

Our latest story on this, dated Aug 12, 2026: "Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/vogenx-prices-ipo-6-250-000-shares-13-00-nasdaq/).

When did Vogenx go public?

Our latest story on this, dated Aug 12, 2026: "Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/vogenx-prices-ipo-6-250-000-shares-13-00-nasdaq/).

Has Vogenx raised money recently?

Our latest story on this, dated Jul 15, 2026: "Vogenx files for IPO, plans Nasdaq Capital Market listing as VOGX". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/vogenx-files-ipo-plans-nasdaq-capital-market-listing-vogx/).

What is the ticker symbol of Vogenx?

Vogenx Inc trades under the ticker VOGX on NASDAQ.

Where is Vogenx listed?

Vogenx Inc is listed on NASDAQ.

What is the SEC CIK of Vogenx?

The SEC Central Index Key (CIK) for Vogenx Inc is 1903784. Its filings are on SEC EDGAR.

How many shares does Vogenx have outstanding?

14,855,087 shares as of 2026-09-17, per the cover page of its 10-Q filed 2026-09-17.

Which country or territory is Vogenx listed under?

Our directory records Vogenx Inc under United States.

What does Vogenx do?

Our directory classifies Vogenx Inc as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Vogenx?

The ISIN recorded for Vogenx Inc is US92859A1060.

Does aibio.space cover Vogenx?

aibio.space lists Vogenx Inc among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Vogenx incorporated?

SEC records list its state or country of incorporation as DE.

What is the latest Vogenx (VOGX) stock news?

Our latest story on Vogenx, dated Aug 12, 2026: "Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq". Vogenx priced 6,250,000 shares at $13.00, for $81,250,000 before underwriting discounts. The prospectus shows $251 thousand of cash at March 31, 2026 and a going-concern warning. [Source](https://aibio.space/news/vogenx-prices-ipo-6-250-000-shares-13-00-nasdaq/).

How long will Vogenx's cash last?

From our story of Aug 12, 2026: The prospectus shows $251 thousand of cash at March 31, 2026 and a going-concern warning. [Source](https://aibio.space/news/vogenx-prices-ipo-6-250-000-shares-13-00-nasdaq/).

Is Vogenx a smaller reporting company?

SEC records list Vogenx Inc's filer category as: <br>Emerging growth company.

## Investor discussion: Vogenx

Members talk about Vogenx (VOGX). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Vogenx, newest first. Each line links the filing it comes from.

1. 2026-08-12 Financings Reported a financing. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1903784/000118518526003448/vogenx424b4081126.htm)
2. 2026-07-15 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1903784/000118518526002985/vogenxs1071026.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:VOGX on TradingView](https://www.tradingview.com/symbols/NASDAQ-VOGX/).

## SEC filings and registration

- **SEC name**: Vogenx, Inc.

- **CIK**: 1903784

- **Industry (SIC)**: Pharmaceutical Preparations (2834)

- **US tickers**: VOGX (Nasdaq)

- **State or country of incorporation**: DE

- **Fiscal year ends**: December 31

- **Filer category**: <br>Emerging growth company

- **Business address**: 3901 BARRETT DRIVE, SUITE 300, RALEIGH, NC, 27609

- **Phone**: 9196595677

- **Shares outstanding**: 14,855,087 as of 2026-09-17 (10-Q filed 2026-09-17)

### Recent filings (8-K and 6-K are the company's own announcements)

- [8-K](https://www.sec.gov/Archives/edgar/data/1903784/000118518526004679/vogenx8k100826.htm) filed 2026-10-09
- [8-K](https://www.sec.gov/Archives/edgar/data/1903784/000118518526004202/vogenx8k092226.htm) filed 2026-09-22
- [10-Q](https://www.sec.gov/Archives/edgar/data/1903784/000118518526004101/vogenx10q063026.htm) filed 2026-09-17
- [8-K](https://www.sec.gov/Archives/edgar/data/1903784/000118518526003628/vogenx8k081826.htm) filed 2026-08-19
- [8-K](https://www.sec.gov/Archives/edgar/data/1903784/000118518526003505/vogenx8k081126.htm) filed 2026-08-13
- [S-1](https://www.sec.gov/Archives/edgar/data/1903784/000118518526002985/vogenxs1071026.htm) filed 2026-07-15

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001903784), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

Vogenx Inc is a public biotech or pharmaceutical company listed on NASDAQ under the ticker VOGX, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Vogenx Inc

- **Ticker**: VOGX

- **Listing**: NASDAQ

- **Country or territory**: United States

- **Business scope**: Pharmaceuticals: Major

- **ISIN**: US92859A1060

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-VOGX/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/vogenx/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Vogenx (VOGX) news: going concern, IPO and offering", 2026-10-31, https://aibio.space/companies/vogenx/